Cargando…
The effect of magnesium supplementation on vascular calcification in chronic kidney disease—a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale
INTRODUCTION: Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular disease and mortality, which is thought to be caused by increased propensity towards vascular calcification (VC). Magnesium (Mg) inhibits phosphate-induced VC in vitro and in animal models and serum Mg...
Autores principales: | Bressendorff, Iain, Hansen, Ditte, Schou, Morten, Kragelund, Charlotte, Brandi, Lisbet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726116/ https://www.ncbi.nlm.nih.gov/pubmed/28645983 http://dx.doi.org/10.1136/bmjopen-2017-016795 |
Ejemplares similares
-
Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial
por: Bressendorff, Iain, et al.
Publicado: (2016) -
The Effect of High Dose Cholecalciferol on Arterial Stiffness and Peripheral and Central Blood Pressure in Healthy Humans: A Randomized Controlled Trial
por: Bressendorff, Iain, et al.
Publicado: (2016) -
MAGiC: A Multimodal Framework for Analysing Gaze in Dyadic Communication
por: Arslan Aydın, Ülkü, et al.
Publicado: (2018) -
Magnesium in CKD: more than a calcification inhibitor?
por: Floege, Jürgen
Publicado: (2014) -
p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway
por: Abe, Rei J., et al.
Publicado: (2020)